BRAF and thyroid gland carcinoma: Furthermore, BRAF (rapidly accelerating fibrosarcoma homolog B) and RAS (rat sarcoma) gene mutations associated with impaired immunity activate the PI3K signaling pathway, enhancing cell growth, survival, and angiogenesis in thyroid cancer cells.34, 35